Biomarkers of Aging Consortium

🎉 Announcing The Longevity Study "Pilot" at the 2024 Biomarkers of Aging Conference. The Longevity Study is a comprehensive longitudinal multi-omics study that is dedicated to understanding human aging and unlocking the potential of cutting-edge aging biomarkers. We invite you to learn more and how you might be able to get involved. 🔗 Learn more about our Pilot: https://lnkd.in/evwpcxGi This is a great opportunity to understand how this study will shape the future of aging biomarkers - and potentially your participation in it. We hope you will find this study of interest. Feel free to reach out to Mahdi Moqri, co-PI and Study Director, for more info.

🌟 2024 Biomarkers of Aging Conference Speaker Highlight 🌟 Tina Woods is the Founder and CEO of Collider Health and Founder and CEO of Business for Health. She is the Healthy Longevity Champion for the National Innovation Centre for Ageing, co-leading the Quantum Healthy Longevity Innovation Mission and City of Longevity programme. Tina sits on various advisory groups, including the XPRIZE Global Visioneering Brain Trust, Strategic Advisory Board for the BBSRC Bioscience for an Integrated Understanding of Health, and BSI standards group for AI in health and care. She is also a trustee for the British Society for Research on Ageing. Join us on November 1-2 at Harvard Medical School for the 2024 Biomarkers of Aging Conference, where Tina and other visionaries and pioneers in longevity will present cutting-edge research on reliable biomarkers of aging for longevity interventions. Ticket sales end in just a few days on October 21st, so be sure to secure your tickets soon! https://buff.ly/3JRDZjn

🌟 2024 Biomarkers of Aging Conference Speaker Highlight 🌟 Prof. Michael Snyder is a renowned leader in functional genomics and proteomics. His lab pioneers integrative personal -omics profiling (iPOP) using cutting-edge technologies to assess disease risk and monitor personalized medicine. Additionally, Dr. Snyder has founded multiple companies, authored a book on genomics and personalized medicine, and serves on several company boards. Join us on November 1-2 at Harvard Medical School for the 2024 Biomarkers of Aging Conference, where Mike and other pioneers in longevity will present cutting-edge research on reliable biomarkers of aging for longevity interventions. Ticket sales end in just a few days on October 21st, so be sure to secure your tickets soon! https://buff.ly/3JRDZjn

🌟 2024 Biomarkers of Aging Conference Speaker Highlight 🌟 Prof. Andrea B. Maier's research focuses on biological age diagnostics and interventions in humans, utilizing cohort studies and randomized controlled trials testing geroprotectors. She launched the evidence-based Healthy Longevity Clinic Chi Longevity in February 2023 in Singapore and opened a healthy longevity clinic in the publicly funded Alexandra Hospital, Singapore, in August 2023. She is also the president of the Healthy Longevity Medicine Society. Join us on November 1-2 at Harvard Medical School for the 2024 Biomarkers of Aging Conference, where Andrea and other pioneers in longevity will present cutting-edge research on reliable biomarkers of aging for longevity interventions. Ticket sales end in just a few days on October 21st, so be sure to secure your tickets soon! https://buff.ly/3JRDZjn

🌟 2024 Biomarkers of Aging Conference Speaker Highlight 🌟 Dr. Chiara Herzog is a researcher at University of Innsbruck, co-PI of a large human multi-omic geroprevention study, and member of the Biomarkers of Aging Consortium Executive Committee. Her interests lie in the successful application of aging biomarkers for human interventions and risk stratification. She will present recent efforts from the consortium to identify barriers to translation and how to overcome them. Join us on November 1-2 at Harvard Medical School for the 2024 Biomarkers of Aging Conference, where Chiara and other pioneers in longevity will present cutting-edge research on reliable biomarkers of aging for longevity interventions. Ticket sales end in just a few days on October 21st, so be sure to secure your tickets soon! https://buff.ly/3JRDZjn

🌟 2024 Biomarkers of Aging Conference Speaker Highlight 🌟 Dr. Xiao-Jun Ma is the CTO of Alamar Biosciences, Inc., a life sciences company developing next-generation proteomic technologies for liquid biopsies. His work focuses on innovation in biomarker technologies such as RNAscope and NULISA, and he also has extensive experience in applying novel technologies to biomarker discovery and diagnostic assay development. Join us on November 1-2 at Harvard Medical School for the 2024 Biomarkers of Aging Conference, where Dr. Ma and other pioneers in longevity will present cutting-edge research on reliable biomarkers of aging for longevity interventions. Ticket sales end in just a few days on October 21st, so be sure to secure your tickets soon! https://buff.ly/3JRDZjn

🌟 2024 Biomarkers of Aging Conference Speaker Highlight 🌟 Prof. Alexandra Stolzing’s research focuses on the cellular mechanisms of aging, aiming to develop strategies to counteract them. In her presentation, she will share her groundbreaking work on detecting and analyzing volatile organic compounds from cell culture airspace and human breath. This innovative project offers a fresh perspective on biomarkers of aging, integrating clinical measures of age-related frailty, recovery, and resilience. Join us on November 1-2 at Harvard Medical School for the 2024 Biomarkers of Aging Conference, where Alexandra and other pioneers in longevity will present cutting-edge research on reliable biomarkers of aging for longevity interventions. Ticket sales end on October 21st, so be sure to secure your tickets by then! https://buff.ly/3JRDZjn

🌟 2024 Biomarkers of Aging Conference Speaker Highlight 🌟 Christin Glorioso, MD PHD is a physician-scientist and co-founder and CEO of NeuroAge Therapeutics, a longevity techbio company that is creating therapies to and biomarkers for reprogramming brain aging. She was previously Head of AI of the Stanford spin-out, TeachAids, and Chief Strategist of the Bakar Aging Research Institute. Christin completed her postdoctoral training at MIT and holds an MD and PhD from the University of Pittsburgh and CMU Medical Scientist Training Program. Join us on November 1-2 at Harvard Medical School for the 2024 Biomarkers of Aging Conference, where Dr. Glorioso and other pioneers in longevity will present cutting-edge research on reliable biomarkers of aging for longevity interventions. Ticket sales end in just a few days, on October 21st, so be sure to secure your tickets by then! https://buff.ly/3JRDZjn

🔥🔥🔥Join us this Wednesday afternoon at @HarvardGSAS! Jesse Poganik Biomarkers of Aging Consortium Jinyeop S. and me will talk about our recent work on #aging biomarkers and AI. This is a hybrid event and food is provided. GSAS Engage Sign-up: https://lnkd.in/gBtkVbkv. Non-harvard participant：https://lnkd.in/g_T9TENm

🌟 2024 Biomarkers of Aging Conference Speaker Highlight 🌟 Professor Gordan Lauc is the Director of the National Centre of Research Excellence in Personalised Healthcare and founder of Genos, Zagreb-based biotech company that is the global leader in high-throughput glycomics. In 2017 he initiated the launch of the Human Glycome project and is one of its two co-directors. By combining glycomic data with extensive genetic, epigenetic, biochemical, and physiological data on over 200,000 individual they are trying to understand the role of glycans in normal physiology and disease. His research led to the development of the GlycanAge test of biological age. Join us on November 1-2 at Harvard Medical School for the 2024 Biomarkers of Aging Conference, where Gordon and other pioneers in longevity will present cutting-edge research on reliable biomarkers of aging for longevity interventions. Ticket sales end on October 21st, so be sure to secure your tickets by then! https://buff.ly/3JRDZjn